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Abstract. 
 
Survival of endothelial cells is critical for cellu-
 
lar processes such as angiogenesis. Cell attachment to ex-
tracellular matrix inhibits apoptosis in endothelial cells
both in vitro and in vivo, but the molecular mechanisms
underlying matrix-induced survival signals or detachment-
induced apoptotic signals are unknown. We demonstrate
here that matrix attachment is an efﬁcient regulator of
Fas-mediated apoptosis in endothelial cells. Thus, matrix
attachment protects cells from Fas-induced apoptosis,
whereas matrix detachment results in susceptibility to
Fas-mediated cell death. Matrix attachment modulates
Fas-mediated apoptosis at two different levels: by regu-
lating the expression level of Fas, and by regulating the
 
expression level of c-Flip, an endogenous antagonist
of caspase-8. The extracellular signal–regulated kinase
(Erk) cascade functions as a survival pathway in adher-
ent cells by regulating c-Flip expression. We further
show that detachment-induced cell death, or anoikis, it-
self results from activation of the Fas pathway by its
ligand, Fas-L. Fas-L/Fas interaction, Fas–FADD com-
plex formation, and caspase-8 activation precede the
bulk of anoikis in endothelial cells, and inhibition of any
 
of these events blocks anoikis. These studies identify
matrix attachment as a survival factor against death
receptor–mediated apoptosis and provide a molecular
mechanism for anoikis and previously observed Fas
resistance in endothelial cells.
Key words: apoptosis • endothelium • extracellular
matrix • integrin • signaling
 
Introduction
 
Endothelium is a critical site for the control of apoptosis
during processes such as inflammation, vascular remodel-
ing, and angiogenesis (Karsan and Harlan, 1996). On one
hand, suppression of apoptosis in endothelial cells is re-
quired for the maintenance of blood vessel integrity and for
angiogenesis. On the other hand, programmed cell death
has been suggested to contribute to pathological tissue de-
struction during vascular injury, inflammation, atheroscle-
rosis, and allograft arteriopathy. It has been proposed that
Fas-mediated apoptosis has a central role in physiological
and pathological turnover in the vasculature. Fas, which be-
longs to the tumor necrosis factor receptor family, induces a
death signal when bound to its ligand, Fas-L (Nagata and
Golstein, 1995). Ligation of Fas receptor induces receptor
aggregation, which in turn results in the recruitment of the
 
adaptor protein Fas-associated death domain (FADD)
 
1
 
 and
caspase-8 and in the activation of downstream caspases that
lead to irreversible cell damage (Krammer, 1996). Expres-
sion of both Fas and Fas-L has been detected in endothelial
cells. It has been demonstrated that one function of the en-
dothelial Fas-L is to inhibit leukocyte extravasation by
 
inducing apoptosis in Fas-expressing mononuclear cells
invading the vessel wall in the absence of normal inflamma-
tory stimuli (Sata and Walsh, 1998c). Endothelial cells
themselves are resistant to Fas-mediated apoptosis under
normal conditions, despite the fact that they express detect-
able Fas on their cell surface (Sata and Walsh, 1998c).
These cells can become dramatically sensitized to Fas-medi-
ated apoptosis in response to specific stimuli or injuries, and
it has been suggested that the increased sensitization to Fas-
mediated apoptosis may play an important role in regula-
tion of pathological tissue destruction in the vessel wall
(Sata and Walsh, 1998b). The mechanisms by which stimuli
sensitize cells to Fas-mediated apoptosis to date have re-
mained largely unelucidated.
Previous studies have indicated that endothelial cells are
dependent on adhesion to the extracellular matrix (ECM)
for their continued survival. Thus, disruption of appropri-
ate cell–matrix contacts both in vitro and in vivo is suffi-
cient to initiate caspase-dependent apoptosis in endo-
thelium, culminating with rapid involution of vascular
structures (Meredith et al., 1993; Brooks et al., 1994; Re et
al., 1994). As a corollary, agents that block appropriate
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 AICD, activation-induced cell death;
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2
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dylinositol 3
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cell–matrix interactions are known to have an important
therapeutic utility in inhibiting tumor-induced neovas-
cularization and tumor progression in animal models
(Brooks et al., 1994). It is known that ligand binding of
integrins, which are the main receptors for ECM pro-
teins, protects cells against detachment-induced apoptosis
or anoikis (for review see Frisch and Ruoslahti, 1997).
More recently, integrin-mediated cell attachment has been
shown to mediate survival signaling against various apop-
totic stimuli, such as serum withdrawal (Zhang et al., 1995;
O’Brien et al., 1996), chemotherapeutic agents (Sethi et
al., 1999), and activation-induced cell death (AICD) in T
lymphocytes (Aoudjit and Vuori, 2000). Focal adhesion
kinase (FAK), which becomes activated upon integrin
ligand binding, mediates survival signaling downstream of
integrins and suppresses anoikis, serum withdrawal–
induced apoptosis, and AICD (Frisch et al., 1996; Hunger-
ford et al., 1996; Ilic et al., 1998; Almeida et al., 2000;
Aoudjit and Vuori, 2000; Gilmore et al., 2000). In addition
to FAK, pathways involving phosphatidylinositol 3
 
9
 
-kinase
(PI 3
 
9
 
-kinase) and the serine/threonine kinase Akt, the
mitogen-activated protein kinase (MAPK)/Erk cascade,
NF-
 
k
 
B, and the Bcl-2 family of proteins have been impli-
cated in integrin-mediated protection against various ap-
optotic stimuli (Zhang et al., 1995; Scatena et al., 1998;
Gilmore et al., 2000; Le Gall et al., 2000; Rosen et al.,
2000). Despite these findings, which have been mainly
made in epithelial cells and fibroblasts, the detailed molec-
ular mechanism as to how integrin signaling leads to cell
survival remains to be determined.
In this study, we hypothesized that the important sur-
vival role that matrix attachment has in endothelial cells
might be due to its capability to regulate Fas-mediated
killing in these cells. We therefore investigated whether
matrix attachment provides protection against Fas-induced
apoptosis and whether detachment-induced apoptosis, or
anoikis, in turn might be caused by activation of the Fas
pathway in endothelial cells. As detailed below, our stud-
ies identify matrix attachment as a survival factor against
death receptor–mediated apoptosis and provide a molecu-
lar mechanism for Fas resistance and anoikis in endothe-
lial cells.
 
Materials and Methods
 
Cells, Antibodies, and Other Reagents
 
Human umbilical vein endothelial cells (HUVECs; Clonetics Corp.) were
cultured in EGM medium (2% FCS, 10 ng/ml hEGF, and 1 
 
m
 
g/ml hydro-
cortisone; Clonetics Corp.), supplemented with 12 
 
m
 
g/ml of bovine brain
extract, 2 mM 
 
L
 
-glutamine, 50 
 
m
 
g/ml streptomycin, and 50 U/ml penicillin
(Irvine Scientific). This medium is termed as “complete growth medium”
below. Anti–Fas-L antibodies, NOK-1, NOK-2, and G247-4 were from
BD PharMingen, and anti–Fas-L antibody clone 33 was from Transduc-
tion Laboratories. Anti-Fas antibodies, ZB4, UB2, and CH11, were from
Kamiya Biomedicals, and anti-Fas antibody clone 13 and anti-FADD anti-
body clone 1 were from Transduction Laboratories. Rabbit polyclonal
anti–c-Flip antibody, which recognizes both Flip
 
L
 
 and Flip
 
S
 
 isoforms, was
obtained from Dr. Donald Nicholson (Merck Frosst, Quebec, Canada).
Anti–
 
a
 
-tubulin and anti–caspase-8 (Ab-1; this antibody recognizes the
p18 fragment of caspase-8) antibodies were from Oncogene Research
Products. The anti–phospho-p44/42 MAPK antibody E10, which recog-
nizes the active form of Erk, was from New England Biolabs, Inc., and the
anti-Erk2 antibody C14 was from Santa Cruz Biotechnology, Inc. The
anti–caspase-8 antibody (clone 5F7; this antibody recognizes the proform
of caspase-8), the caspase-8 and -3 inhibitors (z-IETD-fmk and z-DEVD-
fmk, respectively), and the broad caspase inhibitor z-VAD-fmk were from
Kamiya Biomedicals. The PI 3
 
9
 
-kinase inhibitor Ly294002 and the MAPk
kinase (MEK) inhibitor PD 98059 were from Calbiochem.
 
Plasmids and Transient Transfections
 
HUVECs were transfected by using the Superfect reagent from QIAGEN
according to the manufacturer’s instructions. Cells were grown to 80%
confluency in 6-well plates, and transfected using 5 
 
m
 
g of total DNA. 24 h
later, the cells were washed with PBS and used for subsequent experi-
ments. The plasmids encoding activated and dominant negative forms of
PI 3
 
9
 
-kinase and Akt were obtained from Drs. Jerrold Olefsky (University
of California at San Diego, La Jolla, CA), and Phil Tsichlis (Thomas Jef-
ferson University, Philadelphia, PA), respectively. The plasmids encoding
human c-Flip
 
L
 
, procaspase-8, and dominant negative (dn) FADD cDNAs
were from Drs. John Reed, Guy Salvesen, and Steven Frisch, respectively
(The Burnham Institute). The plasmids encoding Fas and the activated
form of Raf-1 were from Drs. Taka-Aki Sato (Columbia University, New
York, NY) and John Hancock (University of Queensland Medical School,
Brisbane, Australia), respectively.
 
Apoptosis Assay
 
HUVECs grown into 80% confluency were detached by trypsinization,
and anoikis was induced by either keeping cells in complete growth me-
dium (see above) in suspension at 37
 
8
 
C at a concentration of 10
 
5
 
 cells/ml,
or by plating the cells on polyhema at 37
 
8
 
C for the indicated time periods.
Apoptosis was monitored by trypan blue exclusion, by using a cell death
detection ELISA kit (Boehringer), or by staining cells with propidium io-
dide or Hoechst dye, as indicated. For anti-Fas induced apoptosis, the at-
tached cells were incubated for 24 h and the detached cells for 12 h with 1
 
m
 
g/ml of anti-Fas antibody CH11. Apoptosis was monitored as above.
 
Flow Cytometric Analysis
 
3 
 
3
 
 10
 
5
 
 cells in 200 
 
m
 
l of PBS containing 1% FCS and 0.2% sodium azide
(FACS buffer) were incubated with 10 
 
m
 
g/ml of anti-Fas antibody UB2,
anti–Fas-L antibody NOK-1, or isotype-matched control antibodies for 30
min at 4
 
8
 
C. The cells were washed three times in PBS and incubated with
phycoerythrin-conjugated goat anti–mouse IgG secondary antibodies at a
dilution of 1:100 (Jackson ImmunoResearch Laboratories) in 200 
 
m
 
l of
FACS buffer for another 30 min. The cells were washed and immediately
analyzed with a FACScan™ (Becton Dickinson).
 
RNA Isolation and Analysis
 
Total cellular RNA was isolated from HUVECs using the Trizol reagent
(Life Technologies). The first strand cDNA was prepared using the Su-
perscript Amplification System kit (Life Technologies) according to the
manufacturer’s instructions. After reverse transcription, the Flip
 
L
 
 and
Flip
 
S
 
 isoforms were amplified by using specific primers described previ-
ously (Perlman et al., 1999). As a control, glyceraldehyde phosphate dehy-
drogenase (GAPDH) was amplified by using the following primers:
forward, 5
 
9
 
-TTCATTGACCTCAACTACATGG-3
 
9
 
; and reverse, 5
 
9
 
-
GTGGCAGTGATGGCATGGAC-3
 
9
 
. The PCR reaction was carried out
with 1 U Taq polymerase (PerkinElmer) in a total volume of 50 
 
m
 
l. Am-
plification was performed for 28 cycles (30 s denaturing at 94
 
8
 
C, 45 s an-
nealing at 50
 
8
 
C, and 90 s extension at 72
 
8
 
C) in a PerkinElmer thermal cy-
cler. Fas was amplified by using specific primers described previously
(Moulian et al., 1999). Amplification was performed for 35 cycles (1 min
denaturing at 94
 
8
 
C, 1 min annealing at 53
 
8
 
C, and 2 min extension at 72
 
8
 
C).
The PCR products were analyzed by agarose gel electrophoresis.
 
Immunoprecipitation and Immunoblotting
 
The cell lysates for the immunoprecipitations and immunoblotting studies
were prepared as described previously (Aoudjit and Vuori, 2000). To ana-
lyze Fas/Fas-L complex formation and death-inducing signaling complex
formation (DISC), cell lysates prepared from attached and detached cells
were subjected to immunoprecipitations with anti–Fas-L (clone 33) and
anti-FADD antibodies, respectively. Immunoprecipitates and cytosolic
proteins (20 
 
m
 
g of total protein) were analyzed by immunoblotting with
anti-Fas antibodies (clone 13). The blots were stripped and reprobed with
anti–Fas-L (clone 33) and anti-FADD antibodies to assess the amount of
immunoprecipitated protein. In some of the studies, anti–Fas-L antibody 
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G247-4 was used, and similar results were obtained. Protein expression
levels of Fas, Fas-L, and c-Flip were determined by an immunoblot analy-
sis of total cytosolic proteins (20 
 
m
 
g of total protein) by using the respec-
tive antibodies. The blots were stripped and reprobed with anti–
 
a
 
-tubulin
antibody to confirm equal loading. Caspase-8 expression was determined
by immunoblotting (20 
 
m
 
g of total protein) by using the 5F7 antibody
which recognizes the proform of caspase-8. Caspase-8 activity was deter-
mined by an immunoblot analysis (50 
 
m
 
g of total protein) by using an anti-
body (Ab-1) that specifically recognizes the active forms of caspase-8. In
all experiments, immunoblots were visualized by using an HRP-conju-
gated secondary antibody followed by enhanced chemiluminescence de-
tection (Pierce Chemical Co.).
 
Results
 
Matrix Attachment Modulates Fas-mediated Apoptosis 
in HUVECs: Anoikis Is Induced by Activation of the 
Fas/Fas-L Pathway
 
Previous studies have indicated that HUVECs undergo
anoikis when denied matrix attachment (Meredith et al.,
1993; Re et al., 1994), and we found the same here. As
shown in Fig. 1 A, endothelial cell viability decreases by
75% over a 48-h time period after cell detachment in the
presence of serum, and a clear induction (25%) in cell
death is observed 12 h after detachment of the cells. The
loss of cell viability is a result of apoptosis as attested by
the significant induction in DNA fragmentation, a hall-
mark of apoptotic death, after cell detachment (Fig. 1 B).
To examine whether anoikis in HUVECs involves activa-
tion of the Fas/Fas-L pathway, we used inhibitory antibod-
ies against Fas and Fas-L that have been shown previously
to suppress the Fas/Fas-L pathway and inhibit Fas-medi-
ated apoptosis (Kayagaki et al., 1995; Srivastava et al.,
1999). As shown in Fig. 1 C, treatment of detached HU-
VECs with anti–Fas-L antibodies inhibits anoikis in these
cells by 
 
z
 
60%. Inhibitory anti-Fas antibodies, alone or in
combination with the anti–Fas-L antibodies, also signifi-
cantly block anoikis in HUVECs (Fig. 1 C). Several irrele-
vant isotype–matched control antibodies failed to have
any effect on cell survival or anoikis in HUVECs (Fig. 1
C). AICD in T lymphocytes is known to take place via the
Fas/Fas-L pathway, and as a control, we found that AICD
in Jurkat cells can similarly be blocked by 
 
z
 
70% with
anti–Fas-L or anti-Fas antibodies (not shown; Aoudjit and
Vuori, 2000). These antibodies did not have any effect on
serum withdrawal–induced apoptosis in endothelial cells,
which occurs in a Fas-independent manner (not shown).
Thus, these results suggest that activation of Fas by its
ligand, Fas-L, has a significant functional role in the induc-
tion of anoikis in HUVECs.
To examine whether matrix attachment in turn might
protect HUVECs against Fas-mediated apoptosis, adher-
ent HUVECs were treated with an agonistic Fas-antibody,
CH11, to induce activation of Fas signaling. We found that
adherent HUVECs are highly resistant to Fas-mediated
killing (Fig. 2). Upon cell detachment, HUVECs undergo
programmed cell death, as expected, as a result of anoikis.
However, addition of CH11 to detached cells further en-
hances cell death, suggesting that cell detachment sensi-
tizes HUVECs to Fas-mediated apoptosis (Fig. 2). We
used the inhibitory anti–Fas-L antibody to block Fas-
L–dependent induction of Fas signaling in detached cells,
and studied the effect of CH11 under these conditions. As
shown in Fig. 2, a significant amount of apoptosis takes
place in detached, CH11-treated HUVECs, in which Fas-
L–induced apoptosis has been eliminated by the inhibitory
anti–Fas-L antibody. Thus, cell detachment not only in-
duces activation of the Fas pathway by Fas-L, but also sen-
Figure 1. Detachment-
induced apoptosis in
HUVECs is Fas/Fas-L de-
pendent. HUVECs were de-
tached and either kept in
suspension or on polyhema-
coated dishes in complete
growth medium (EGM me-
dium containing 2% FCS, 10
ng/ml hEGF, and 1 mg/ml hy-
drocortisone, supplemented
with 12 mg/ml of bovine brain
extract, 2 mM L-glutamine,
50  mg/ml streptomycin, and
50 U/ml penicillin) for the in-
dicated time periods, and cell
death was determined by (A)
trypan blue exclusion or (B)
DNA fragmentation analysis.
Identical results were ob-
tained under the two experi-
mental conditions; results
shown are for cells kept in
suspension, and these experi-
mental conditions were used
in all subsequent experi-
ments involving detachment-
induced cell death. (C) HU-
VECs were kept adherent or
in suspension for 12 h in the
presence or absence of 5 mg/ml of inhibitory anti–Fas-L antibod-
ies (NOK-2), inhibitory anti-Fas antibodies (ZB4), or with con-
trol antibodies (IgG). Apoptosis was determined by DNA frag-
mentation analysis. In A and B, results are shown for
representative experiments independently carried out three
times. In C, bars indicate SD in a representative experiment done
in triplicate.
Figure 2. Cell detachment sensitizes HUVECs to Fas-mediated
apoptosis. The ability of agonistic anti-Fas antibody (CH11) to
induce apoptosis was analyzed in attached and detached HU-
VECs. The cells were incubated with or without 1 mg/ml of CH11
for 12 h in the presence or absence of blocking anti–Fas-L anti-
body (NOK-2), and apoptosis was determined by DNA fragmen-
tation analysis. Bars indicate SD in a representative experiment
done in triplicate. 
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sitizes endothelial cells to activation of Fas-mediated apop-
tosis by exogenously added Fas agonists.
 
Cell Detachment Induces Fas/Fas-L Interaction, DISC 
Formation, and Caspase-8 Activation in HUVECs
 
To further examine the role of the Fas/Fas-L pathway in
anoikis, we undertook several biochemical approaches to
study Fas signaling in detached endothelial cells. First, we
examined whether cell detachment induces Fas/Fas-L in-
teraction in HUVECs. As shown in Fig. 3 A, Fas becomes
associated with Fas-L after detachment of HUVECs, and
this association precedes induction of the bulk of anoikis
in these cells (see Fig. 1 A). Thus, Fas/Fas-L association
can be clearly detected 6 h after cell detachment, the inter-
action peaking 12 h after detachment of the cells. Impor-
tantly, the molecular mass of Fas detected in the Fas-L im-
munoprecipitates is 110 kD, which corresponds to the
oligomerized form of Fas that is induced after binding of
Fas-L to Fas (Kamitani et al., 1997).
Fas engagement and trimerization of Fas lead to the re-
cruitment of FADD to form the DISC. FADD in turn re-
cruits procaspase-8, which is cleaved and activated at the
DISC. As shown in Fig. 3 B, HUVEC detachment induces
DISC formation, as attested by the coimmunoprecipitation
of oligomerized Fas and FADD. This interaction peaks 12 h
after cell detachment, and decreases 24 h after detachment
of the cells. To confirm that FADD has a functional role in
anoikis in HUVECs, the cells were transiently transfected
with a control vector or with an expression vector coding
for dnFADD. As shown in Fig. 3 C, expression of dnFADD
significantly blocks anoikis at all time points examined. In
a control experiment, we found that AICD in Jurkat cells
is also blocked by dnFADD (not shown).
We next determined whether cell detachment results in
activation of caspase-8, and if so, whether activation of
caspase-8 is necessary for anoikis in HUVECs. After Fas
activation, caspase-8 undergoes several processing steps to
generate the active caspase-8 heterodimer composed of
p18 and p10/12 (Salvesen, 1999). As shown in Fig. 3 D, de-
tachment of HUVECs results in the generation of the p18
active form of caspase-8, which peaks 12 h after cell de-
tachment. Activation and processing of caspase-8 is signifi-
cantly blocked by a specific inhibitor of caspase-8, z-IETD-
fmk (Fig. 3 D). Further, activation of caspase-8 was found
to be necessary for anoikis to take place in HUVECs,
as z-IETD-fmk also significantly blocked detachment-
induced apoptosis in these cells. As a control, we found
 
tored apoptosis by staining the cells with Hoechst dye and found
that results obtained with propidium iodide and Hoechst were in-
distinguishable from each other (not shown). Thus, the results
obtained with the Hoechst dye confirm that cell death observed
under our experimental conditions results from apoptosis, rather
than necrosis. (D) HUVECs were left adherent or kept in sus-
pension for 12 h in the presence or absence of the indicated con-
centrations of caspase-8 inhibitor z-IETD-fmk. In the left panel,
apoptosis was determined by DNA fragmentation analysis; bars
indicate SD in a representative experiment done in triplicate. In
the right panel, cell lysates were prepared and analyzed by immu-
noblotting with an anti–caspase-8 antibody (Ab-1) that detects
the p18 active form of the enzyme.
 
Figure 3.
 
Cell detachment induces Fas/Fas-L interaction, DISC
formation, and caspase-8 activation in HUVECs. Inhibition of
anoikis by dnFADD and caspase-8 inhibitors. (A) Cell lysates
were prepared from adherent HUVECs and from HUVECs that
had been kept in suspension for the indicated times, and the ly-
sates were subjected to immunoprecipitation analysis by anti–
Fas-L antibodies (clone 33). Immunoprecipitates (IP) were ana-
lyzed by immunoblotting with anti-Fas antibodies (clone 13; top).
The membranes were stripped and reprobed with anti–Fas-L an-
tibodies (clone 33) to confirm equal amounts of Fas-L in the pre-
cipitates (bottom). Similar results were obtained when anti–Fas-L
antibody G247-4 was used (data not shown). (B) The cell lysates
were subjected to immunoprecipitations by anti-FADD antibod-
ies. The immunoprecipitates were analyzed by immunoblotting
with anti-Fas antibodies (clone 13; top), and the membranes were
stripped and reprobed with anti-FADD antibodies to confirm
equal amounts of FADD in the precipitates (bottom). C, Control
cell lysate prepared from Jurkat T cells that had been activated
by T cell receptor stimulation. (C) HUVECs were transiently
transfected with an empty vector (control) or with an expression
plasmid encoding dnFADD, together with plasmid coding for the
green fluorescent protein (GFP). 24 h after transfection, the cells
were either kept adherent or kept in suspension for the indicated
time periods. The cells were then washed and propidium iodide
was added for 20 min on ice. Apoptosis analysis by FACS
 
®
 
 was
carried out in the double positive cell population for propidium
iodide and fluorescent GFP. In a separate experiment, we moni- 
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that z-IETD-fmk completely blocks AICD in Jurkat cells,
whereas it has no effect on serum withdrawal–induced ap-
optosis in endothelial cells (data not shown). Thus, several
lines of biochemical evidence support the notion that the
Fas/Fas-L signaling pathway is activated in detached en-
dothelial cells and contributes to the induction of anoikis.
 
Matrix Attachment Regulates Expression Levels of Fas 
and Fas-L in HUVECs
 
One possible explanation as to how matrix attachment
could control Fas-mediated apoptosis is by regulating the
expression levels of key components of Fas signaling, such
as Fas-L and Fas. Similar to what has been reported previ-
ously with respect to HUVECs cultured as a monolayer, we
found that adherent HUVECs express significant levels of
Fas-L (not shown). Cell detachment did result, however, in
a 1.5-fold increase in the cell surface levels of Fas-L (not
shown). However, the fact that high amounts of Fas-L are
expressed in attached cells and that Fas-L expressed on
HUVECs is functional and capable of inducing Fas-medi-
ated killing in target cells (data not shown; Sata and Walsh,
1998c) led us to conclude that adhesion-mediated regula-
tion of Fas-L cell surface levels is unlikely to be a rate-limit-
ing step in Fas-mediated apoptosis and anoikis in HUVECs.
We then examined the expression levels of Fas in at-
tached and detached HUVECs. As reported previously,
HUVECs cultured as a monolayer express detectable lev-
els of Fas (Fig. 4 A). Detachment of HUVECs results in a
threefold increase in the cell surface levels of Fas by 12 h
after detachment (Fig. 4 A). The detachment-induced in-
crease in Fas expression can be detected also at the
mRNA level. A semiquantitative reverse transcriptase
(RT)-PCR analysis of Fas mRNA expression indicates
that cell detachment induces an increase in Fas mRNA
levels as early as in 3 h, with a peak in the induction of Fas
mRNA levels occurring 6 h after cell detachment (Fig. 4
B). To examine whether matrix attachment protects en-
dothelial cells from Fas-mediated apoptosis by downregu-
lating the cell surface levels of Fas, attached HUVECs
were transiently transfected with a plasmid coding for Fas.
In several independent experiments, transient transfection
resulted, on average, in a two- to threefold increase in the
cell surface levels of Fas (not shown). However, ectopic
expression of Fas did not result in an induction of apopto-
sis in attached HUVECs, and neither did it sensitize the
cells to CH11-mediated killing (see Fig. 6). Thus, although
upregulation of Fas may be necessary for anoikis and Fas-
mediated apoptosis to take place in detached cells, en-
hanced Fas expression alone is not sufficient to sensitize
adherent HUVECs for Fas-mediated killing. Upon exami-
nation of DISC formation and caspase-8 activation in
Fas-transfected, CH11-treated HUVECs, we observed
Fas–FADD interaction but no caspase-8 activation (not
shown). Taken together, these results suggest that matrix
attachment regulates (at least) one additional step in Fas
signaling, which takes place downstream of DISC forma-
tion but upstream or at the level of caspase-8 activation.
 
Role of c-Flip in Adhesion-dependent Regulation of
Fas Signaling
 
Previous reports have demonstrated that Fas-mediated
apoptosis can be modulated at the level of caspase-8 acti-
vation by a mechanism that involves c-Flip, an endogenous
caspase-8 inhibitor (Irmler et al., 1997), and it has been
suggested that the balance between the expression levels
of c-Flip and caspase-8 may control the sensitivity of a
given cell to Fas-mediated killing (Scaffidi et al., 1999).
Two different isoforms of c-Flip, namely Flip long (Flip
 
L
 
)
and Flip short (Flip
 
S
 
), have been detected in various cell
types and both isoforms are known to interfere with
caspase-8 activation (Irmler et al., 1997; Scaffidi et al.,
1999). As shown in Fig. 5 A, both Flip
 
L
 
 and Flip
 
S
 
 are ex-
pressed at relatively high levels compared with caspase-8
in adherent HUVECs. However, in HUVECs that have
been detached for 8 h, the c-Flip protein levels are signifi-
cantly reduced compared with caspase-8 levels (the appar-
ent disappearance of the proform of caspase-8 protein is
due to the processing of the protein that takes place during
caspase-8 activation). To study the levels of c-Flip in de-
tached HUVECs in detail, a time course analysis of the
protein (Fig. 5 B, top) and mRNA levels (as measured by
semiquantitative RT-PCR; Fig. 5 B, bottom) of Flip
 
L
 
 and
Flip
 
S
 
 were carried out. Our findings indicate that HUVEC
detachment induces a rapid reduction of Flip
 
L
 
 and, more
notably, Flip
 
S
 
 at both mRNA and protein levels. A clear
decrease in Flip protein can be detected as early as 6 h af-
ter cell detachment, demonstrating that the reduction in
the c-Flip protein levels precedes the bulk of caspase-8 ac-
Figure 4. Cell detachment upregulates Fas expression in HU-
VECs. (A) Detachment induces cell surface levels of Fas. HU-
VECs were kept adherent or in suspension for 12 h. FACS® analy-
sis with anti-Fas antibody (UB2) was carried out as described in
Materials and Methods. (B) Cell detachment increases the mRNA
levels of Fas. HUVECs were kept adherent or in suspension for
the indicated times, and Fas mRNA levels were determined by an
RT-PCR analysis as described in Materials and Methods. 
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tivation and anoikis observed in detached HUVECs.
Thus, matrix attachment and detachment may control Fas-
mediated apoptosis and caspase-8 activation by regulating
the levels of the caspase-8 antagonist, c-Flip.
To analyze the putative functional role of c-Flip in adhe-
sion-dependent regulation of anoikis and Fas-mediated
apoptosis, two lines of experimentation were undertaken.
First, exogenous c-Flip was expressed in detached HU-
VECs at levels that mimic the c-Flip/caspase-8 ratio ob-
served in adherent cells, and anoikis was monitored in the
resulting cells. As shown in Fig. 5 C, exogenous expression
of c-Flip blocks anoikis by 
 
z
 
75%. As shown in Fig. 5 D,
expression of c-Flip inhibits caspase-8 activation in de-
tached cells, up to 30% of the inhibition that is observed
when detached cells are treated with the specific caspase-8
inhibitor, z-IETD-fmk. Note that caspase-8 activity, which
is measured by the appearance of the p18 active form of
caspase-8, is monitored in the total pool of c-Flip–trans-
fected cells, and we estimate that the transient transfection
efficiency achieved in the cells is 
 
z
 
30% (not shown).
Thus, c-Flip appears to be a highly efficient inhibitor of
caspase-8 in HUVECs. Taken together, these studies indi-
cate that downmodulation of c-Flip during cell detach-
ment may be a necessary and causal event in detachment-
induced caspase-8 activation and HUVEC anoikis.
In a reciprocal experiment, exogenous caspase-8 was ex-
pressed in attached HUVECs to mimic the c-Flip/caspase-8
ratio observed in detached cells, and the susceptibility of
the cells for Fas-induced apoptosis was analyzed. As
shown in Fig. 6, exogenous expression of caspase-8 alone
does not induce apoptosis in HUVEC cells, nor does it
make the cells sensitive to CH11-induced apoptosis. How-
ever, exogenous expression of both caspase-8 and Fas ren-
ders HUVECs sensitive to CH11-mediated killing (Fig. 6).
Note, though, that exogenous expression of Fas and
caspase-8 does not induce apoptosis in non–CH11-treated
cells, despite the fact that the cells express endogenous
Fas-L (see Discussion). In conclusion, it appears that cell
adhesion regulates anoikis and Fas-mediated apoptosis (at
least) at two different levels: first, by regulating the cell
surface levels of Fas, thereby controlling the availability of
the death receptor for its ligand; and second, by regulating
the expression levels of c-Flip, thereby controlling death
receptor–induced activation of caspase-8.
 
Roles of the PI 3
 
9
 
-kinase/Akt and Erk Survival 
Pathways in HUVECs
 
In many cell types, matrix attachment has been shown to re-
sult in activation of the PI 3
 
9
 
-kinase/Akt and MAPK/Erk
pathways, whereas cell detachment is known to downregu-
late these activities (for review see Giancotti and Ruoslahti,
1999; Schlaepfer et al., 1999). Furthermore, activation of the
PI 3
 
9
 
-kinase/Akt and the Erk pathways has been shown to
protect MDCK and CCL39 cells, respectively, against de-
tachment-induced cell death (Khwaja et al., 1997; Le Gall et
al., 2000). We found that matrix attachment activates and
matrix detachment inactivates the two pathways in HU-
VECs (results for the Erk pathway are shown in Fig. 8 B),
and we therefore decided to examine the role of these two
survival pathways in adhesion-mediated protection against
Fas-induced apoptosis and anoikis in endothelial cells.
Figure 5. Cell detachment results in downmodula-
tion of c-Flip expression. Exogenous expression of
c-Flip protects HUVECs from anoikis and prevents
caspase-8 activation in detached cells. (A) Cell ly-
sates were prepared from adherent HUVECs and
from HUVECs that had been kept in suspension for
8 h, and the lysates were subjected to immunoblot-
ting analysis by antibodies against c-Flip (top),
caspase-8 (5F7; middle), and tubulin (bottom). (B)
c-Flip expression was determined in attached cells or
in cells that had been kept in suspension for the indi-
cated times by immunoblot analysis (top two panels)
and by RT-PCR (bottom three panels). As a control,
protein expression levels in the lysates were ana-
lyzed by antitubulin immunoblotting (top), and
mRNA expression levels by RT-PCR analysis with
primers specific for GAPDH (bottom). The relative
expression levels of Flip proteins as quantitated with
a densitometric analysis are indicated. (C) Exoge-
nous expression of c-Flip protects HUVECs from
anoikis. HUVECs were cotransfected with an empty
vector (control) or with plasmid encoding c-FlipL, to-
gether with plasmid coding for GFP. 24 h after trans-
fection, the cells were either kept adherent or in sus-
pension for 12 h. Apoptosis analysis by FACS® was
carried out in the double positive cell population for
propidium iodide and fluorescent GFP as described above. Bars indicate SD in a representative experiment done in triplicate. (D) Ex-
ogenous expression of c-Flip blocks caspase-8 activation in detached HUVECs. HUVECs were transiently transfected with an empty
vector or with plasmid encoding c-FlipL. 24 h after transfection, the cells were kept adherent or in suspension for 12 h. In some of the ex-
periments, the cells were simultaneously treated with 20 mM of the caspase-8 inhibitor z-IETD-fmk, as indicated. The cell lysates were
analyzed by immunoblotting with an anti–caspase-8 antibody (Ab-1) that detects the p18 active form of the enzyme. The membrane was
stripped and reprobed with an anti–a-tubulin control antibody to confirm equal loading (bottom). 
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We first examined whether constitutive activation of the
PI 3
 
9
 
-kinase/Akt pathway or the Erk pathway in detached
HUVECs would protect these cells against anoikis. As
shown in Fig. 7, expression of constitutively activated PI
3
 
9
 
-kinase (p110*), Akt (myr-Akt), or c-Raf-1 (Raf-CAAX;
this construct constitutively activates the Erk pathway)
(Kazama and Yonehara, 2000) inhibits anoikis by 50–80%
compared with control transfected cells, demonstrating
that exogenous activation of either the PI 3
 
9
 
-kinase/Akt or
the Erk pathway mediates survival signaling that is suffi-
cient to block anoikis in HUVECs.
 
The Erk Pathway Regulates c-Flip Expression
in HUVECs
 
Exogenous expression of activated PI 3
 
9
 
-kinase or Akt
had no effect on the expression levels of Fas, Fas-L, or
c-Flip, suggesting that the PI 3
 
9
 
-kinase/Akt pathway exerts
its cell survival effect on anoikis through a different mech-
anism (data not shown; see Discussion). Also, exogenous
expression of activated c-Raf-1 had no effect on the ex-
pression levels of Fas and Fas-L in HUVECs (data not
shown). As shown in Fig. 8 A, exogenous expression of ac-
tivated c-Raf-1 results in a slight increase in the mRNA
and protein levels of both Flip
 
L
 
 and Flip
 
S
 
 in attached cells.
Importantly, expression of activated c-Raf-1 almost com-
pletely prevents downregulation of Flip
 
L
 
 and Flip
 
S
 
 mRNA
and protein levels in detached cells. As a control experi-
ment, we found that expression of activated c-Raf-1 results
in an increase in Erk phosphorylation in HUVEC cells;
notably, expression of activated c-Raf-1 significantly blocks
downregulation of Erk activity in detached cells (Fig. 8 E).
Keeping in mind the finding that activated PI 3
 
9
 
-kinase
and Akt block anoikis in HUVECs without affecting the
expression levels of c-Flip, it is unlikely that the effect of
c-Raf-1 on c-Flip expression is secondary to enhanced sur-
vival of the cells. As a further support for this, we found
that the broad spectrum caspase inhibitor z-VAD blocks
anoikis in HUVEC cells, but has no effect on Flip expres-
sion in detached cells (not shown). Thus, we conclude that
the suppressive effect that the Raf/Erk pathway has on
anoikis is likely to be due, at least in part, to Raf/Erk-
mediated upregulation of c-Flip.
As a corollary to these findings, inactivation of the Erk
pathway upon cell detachment may be necessary for down-
regulation of c-Flip expression levels, caspase-8 activation,
and anoikis to take place in HUVECs. Furthermore, the
Raf/Erk pathway may in turn mediate upregulation of
c-Flip expression in attached HUVECs, and thereby func-
tion as a survival pathway in adherent cells, protecting
them against Fas-mediated apoptosis. As shown in Fig. 8
B, Erk activity is downregulated in a time-dependent man-
ner upon HUVEC detachment, and, importantly, this
downregulation precedes downregulation of c-Flip expres-
sion (see Fig. 5) and induction of anoikis (see Fig. 1) in de-
tached HUVECs. To characterize the putative functional
role of the Erk pathway in regulating c-Flip expression and
Fas-mediated apoptosis in attached HUVECs, we used the
Mek1 inhibitor PD90839 to block attachment-induced Erk
activation in adherent endothelial cells. As shown in Fig. 8,
treatment of attached HUVECs with PD90839 results in a
strong inhibition of Erk kinase activity (Fig. 8 B) and in re-
duction of both mRNA and protein levels of c-Flip in at-
tached endothelial cells (Fig. 8 C). Thus, Erk activity ap-
pears to be necessary for the upregulation of c-Flip
expression in adherent endothelial cells. We further found
that Erk activity is required for attachment-mediated pro-
tection against Fas-induced apoptosis. Attached HUVECs
were transiently transfected to express Fas, the cells were
treated or not treated with the Mek1 inhibitor, and the sus-
ceptibility of the cells to CH11-mediated apoptosis was an-
alyzed. As shown in Fig. 8 D, treatment of Fas-expressing
cells with the Mek1 inhibitor sensitizes attached HUVECs
to Fas-mediated apoptosis. Thus, the Erk pathway func-
tions as a survival pathway in attached HUVECs to pro-
tect against Fas-mediated apoptosis, and this protection, at
least in part, is likely to be due to regulation of c-Flip ex-
pression by the Erk kinase cascade.
 
Discussion
 
Recent experimental evidence has demonstrated that inhi-
bition of endothelial cell apoptosis is an essential prerequi-
site to maintain vascular remodeling and angiogenesis.
Figure 6. Exogenous expres-
sion of both Fas and caspase-
8 is required to render at-
tached HUVECs sensitive
to Fas-mediated apoptosis.
HUVECs were transfected
with an empty vector (con-
trol), or with plasmids encod-
ing Fas and procaspase-8, to-
gether with plasmid coding
for the GFP. 24 h after trans-
fection, the cells were stimu-
lated or not for an additional 24 h with 1 mg/ml of anti-Fas anti-
body CH11. Apoptosis analysis by FACS® was carried out in the
double positive cell population for propidium iodide and fluores-
cent GFP as described above. Bars indicate SD in a representa-
tive experiment done in triplicate.
Figure 7. Ectopic activation of the PI 39-kinase/Akt and Erk path-
ways prevents anoikis in HUVECs. HUVECs were cotransfected
with an empty vector (control) or with plasmids encoding acti-
vated forms of PI 39-kinase (p110*), Akt (Myr-Akt), and c-Raf-1
(Raf-CAAX), together with a plasmid coding for GFP. After
transfection, the cells were kept adherent or in suspension for
24 h. Apoptosis was determined by using FACS® in the double
positive cell population for GFP and propidium iodide as described
above. Bars indicate SD in an experiment done in triplicate. 
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Appropriate endothelial cell–extracellular matrix interac-
tions are known to be required for endothelial cell viabil-
ity both in vitro and in vivo, but at present, molecular
mechanisms that couple adhesion-dependent survival sig-
naling to the antiapoptotic machinery in endothelial cells
remain largely unknown. Our present findings provide
several novel insights into the mechanisms that regulate
endothelial cell survival and apoptosis. First, we demon-
strate that cell–matrix interaction has a profound effect in
regulating Fas-mediated apoptosis in HUVECs. Thus, we
find that adherent endothelial cells are resistant to Fas-
mediated apoptosis, even when significant levels of Fas
receptor are expressed on the cell surface. Second, we
identify the molecular mechanisms as to how matrix at-
tachment regulates Fas-mediated apoptosis, namely by
regulating the expression levels of Fas, thereby controlling
the availability of the death receptor for its ligand, and by
regulating the expression levels of c-Flip, thereby control-
ling death receptor–induced activation of caspase-8. Third,
we find that detachment-induced cell death, or anoikis,
takes place as a result of activation of the Fas/Fas-L death
pathway, and our results therefore provide a molecular
mechanism for anoikis in endothelial cells.
Fas, also known as APO-1 or CD95, is one of the best
characterized members of the death receptor family. It has
been suggested that the increased sensitization to Fas-
mediated apoptosis may play an important role in regula-
tion of pathological tissue destruction, but the mechanisms
by which stimuli sensitize cells to Fas-mediated apoptosis
have remained to be elucidated. Our finding that matrix
attachment is a powerful regulator of Fas-mediated apop-
tosis provides one of the first insights into the regulatory
mechanisms that determine the responsiveness of cells to
Fas-induced killing. As discussed below in more detail, our
results indicate that c-Flip, an antagonist of caspase-8, has
a crucial role in adhesion-dependent survival signaling.
Taking into consideration the central role of caspase-8 in
induction of apoptosis by several tumor necrosis factor
family death receptors, it is plausible to assume that matrix
attachment regulates apoptosis triggered by other death
receptors as well. Further, recent studies have indicated
that cell attachment mediates cell survival against serum
starvation and growth factor withdrawal–induced apopto-
sis (see Introduction), and in many cases these forms of
cell death are initiated and activated at the level of mito-
chondria, rather than by cell surface death receptors. Our
finding that cell attachment to ECM provides survival sig-
naling against Fas, and possible other death receptor–
induced apoptosis, supports an emerging role for ECM as
a crucial survival factor against most, if not all, forms of
programmed cell death.
While cell attachment to matrix provides survival signal-
ing against various apoptotic stimuli, detachment of cells,
without addition of exogenous death stimuli, induces ap-
optosis in epithelial and endothelial cells. This mechanism,
known as anoikis, ensures that these cells do not normally
Figure 8. The Erk pathway functions as a survival pathway in
attached HUVECs and modulates c-Flip expression. (A) Exog-
enous expression of activated Raf-1 enhances c-Flip expression
in detached HUVECs. HUVECs were transfected with an
empty vector (Control) or with a plasmid encoding activated
form of c-Raf-1 (Raf-CAAX). After transfection, the cells were
kept adherent or in suspension for 24 h. c-Flip expression was
determined by immunoblot analysis (top) and by RT-PCR
(bottom). (B) Cell detachment results in the inactivation of the
MAPK/Erk pathway in a time-dependent manner. HUVECs were kept
adherent or in suspension for the indicated times. Cell lysates were pre-
pared and Erk activation was determined by an immunoblot analysis with
an anti–phospho-Erk1/2 antibody (top). The membrane was stripped and
reprobed with an anti-Erk2 antibody to confirm equal loading (bottom).
As indicated, in one of the experiments, the effectiveness of the MEK in-
hibitor PD98059 was analyzed by treating adherent HUVECs for 16 h be-
fore cell lysis. (C) Inhibition of the Erk pathway in adherent HUVECs
downregulates c-Flip expression. HUVECs were treated or not with the
MEK inhibitor PD98059 for 16 h and c-Flip expression was determined
by immunoblotting (top) and by RT-PCR (bottom). (D) Inhibition of the
Erk pathway in adherent HUVECs sensitizes the cells to Fas-mediated
apoptosis. HUVECs were transiently transfected with an empty control
vector or with a plasmid encoding Fas, together with plasmid coding for
GFP. After transfection, the cells were treated or not with 25 mM of the
MEK inhibitor PD98059 in the presence or absence of 1 mg/ml of the
anti-Fas antibody CH11 for 24 h. Apoptosis analysis by FACS® was car-
ried out in the double positive cell population for propidium iodide and
fluorescent GFP as described above. Bars indicate SD in a representative
experiment done in triplicate. (E) Exogenous expression of activated
Raf-1 enhances Erk phosphorylation in HUVECs. HUVECs were trans-
fected with an empty vector (Control) or with a plasmid encoding acti-
vated form of c-Raf-1 (Raf-CAAX). After transfection, the cells were
kept adherent or in suspension for 12 h. Cell lysates were prepared and
Erk activation was determined by an immunoblot analysis with an anti–
phospho-Erk1/2 antibody (top). The membrane was stripped and re-
probed with an anti-Erk2 antibody to confirm equal loading (bottom). 
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survive in the absence of the correct interaction with ECM
and therefore are unable to proliferate in an inappropriate
location (Frisch and Ruoslahti, 1997). Until recently, the
molecular mechanisms that regulate anoikis have re-
mained largely unknown. In the present study, we demon-
strate by several biochemical means that activation of the
Fas/Fas-L pathway takes place upon endothelial cell de-
tachment and that activation of this pathway precedes
anoikis in HUVECs. By using various inhibitory reagents
against Fas-L, Fas, and the components of the downstream
signaling pathway, we show that Fas-L–mediated activa-
tion of the Fas pathway is causal to anoikis in HUVECs.
Previously, involvement of a death receptor pathway has
been implicated in anoikis in epithelial cells (Frisch, 1999;
Rytomaa et al., 1999). In these studies, it was shown that
anoikis can be blocked by dnFADD and by inhibitors of
caspase-8. However, soluble extracellular domains of vari-
ous death receptors failed to block anoikis, and the au-
thors therefore concluded that ligand-dependent activa-
tion of death receptors is unlikely to be involved in anoikis
(Rytomaa et al., 1999). In our studies, we have not used
soluble extracellular domains as inhibitors, but rather ap-
plied inhibitory antibodies against Fas and Fas-L. These
antibodies have been widely used as specific inhibitors
against Fas-mediated apoptosis by several investigators
(Kayagaki et al., 1995; Srivastava et al., 1999). Our studies
demonstrate that the bulk of anoikis in endothelial cells is
mediated by the Fas/Fas-L interaction, although we can-
not rule out the possibility that other death receptors
could also have some role in anoikis in endothelial cells. It
also remains to be determined whether our findings are
applicable to all types of endothelial cells. While the de-
tailed mechanism of anoikis is not known in epithelial
cells, it is possible that endothelial and epithelial cells uti-
lize slightly different pathways to activate the death ma-
chinery upon cell detachment.
Our results indicate that matrix adhesion regulates the
expression levels of Fas-L, Fas, and c-Flip, but not of sev-
eral other components of the Fas pathway, such as
caspase-8 and FADD (not shown). Most significantly, de-
tachment of cells was found to result in an enhancement of
Fas expression and in downregulation of Flip expression,
and both of these events preceded anoikis in HUVECs.
We further found that enhanced Fas expression is neces-
sary, but not sufficient, to sensitize attached HUVECs to
Fas-induced apoptosis. This finding is in agreement with a
recent report, in which it was shown that interferon-
induced Fas expression is not sufficient to sensitize HU-
VECs to Fas-induced cell death (Sata et al., 2000). In
addition to enhanced Fas expression, we found that modu-
lation of the caspase-8/c-Flip ratio to favor caspase-8 acti-
vation is necessary for Fas-induced apoptosis to occur in
attached HUVECs. In a reciprocal experiment, we found
that enhanced expression of c-Flip in detached cells is suf-
ficient to inhibit caspase-8 activation and anoikis in HU-
VECs. Our results therefore identify regulation of Fas and
Flip expression levels as a key event in adhesion-depen-
dent control of Fas-mediated apoptosis.
Recent studies using Flip-null fibroblasts have demon-
strated that Flip proteins, which structurally resemble
caspase-8 except that they lack proteolytic activity, have a
crucial role in death factor–induced apoptosis (Yeh et al.,
 
2000). At present, the relative roles of the two splice vari-
ants of c-Flip, Flip
 
L
 
 and Flip
 
S
 
, remain to be elucidated. It
has been recently demonstrated that in T cell receptor–
restimulated T cells, amounts of Flip
 
L
 
 are slightly changed,
whereas there is a significant change in the amount of
Flip
 
S protein expression, and the authors conclude that it
is the change in the levels of FlipS that is responsible for
the Fas-resistant phenotype in this model system (Kirch-
hoff et al., 2000). We have similarly found that cell attach-
ment mainly affects the levels of FlipS (see Fig. 5), and it
may be that also in our model system FlipS has a more
dominant role in the inhibition of Fas-mediated apoptosis.
Relatively little is also known about the physiological and
pathological stimuli that modulate Flip expression. Our re-
sults demonstrate, for the first time, Flip regulation by cell
adhesion receptors. Our findings also add to the emerg-
ing notion that regulation of Flip may have a crucial role
in controlling endothelial cell survival. Sata and Walsh
(1998a) have recently demonstrated that endothelial cell
apoptosis induced by oxidized low density lipoprotein is
associated with downregulation of Flip. Modulation of
Flip has also been linked to angiogenesis; a recombinant
fragment derived from the a2 chain of type IV collagen,
termed canstatin, has antiangiogenic activity, and it has
been reported that canstatin-induced endothelial cell ap-
optosis coincides with downregulation of Flip (Kamphaus
et al., 2000). By using several lines of investigation, we
found that the MAPK/Erk pathway regulates Flip expres-
sion and Fas-mediated apoptosis in HUVECs. In addition
to our findings here, a recent report indicates that the Erk
pathway regulates c-Flip also in T lymphocytes (Yeh et al.,
1998). Of note, the avb3 integrin, which mediates endo-
thelial cell survival in vivo, has been shown to be necessary
for sustained Erk activation during angiogenesis (Eliceiri
et al., 1998). It remains to be determined whether the avb3
integrin regulates c-Flip expression in vivo, and whether
the Erk pathway has a central role in controlling Flip in
cellular systems other than endothelial cells and lympho-
cytes. While we found that adhesion-dependent modula-
tion of the Erk pathway is both necessary and sufficient to
regulate c-Flip levels in endothelial cells, our results indi-
cate that this pathway is not involved in regulating the ex-
pression levels of Fas and Fas-L (data not shown). Experi-
ments addressing how matrix attachment regulates Fas
and Fas-L expression in HUVECs are currently ongoing.
In epithelial cells, disruption of the PI 39-kinase/Akt
pathway in attached cells leads to apoptosis, whereas ex-
ogenous expression of activated forms of PI 39-kinase and
Akt protects epithelial cells against anoikis (Khwaja et al.,
1997). We found here that exogenous expression of acti-
vated PI 39-kinase and Akt blocks anoikis in endothelial
cells. However, treatment of attached HUVECs with in-
hibitors that disrupt the PI 39-kinase/Akt pathway did not
lead to apoptosis or to sensitization of the cells to anti-
Fas–induced apoptosis (data not shown). However, fur-
ther activation of the PI 39-kinase/Akt pathway in at-
tached cells provided additional survival signaling in
endothelial cells. Thus, we found that expression of acti-
vated forms of PI 39-kinase and Akt suppressed CH11-
induced apoptosis in Fas- and caspase-8–transfected, at-
tached HUVECs (not shown). It is also known that
treatment of HUVECs with vascular endothelial growthThe Journal of Cell Biology, Volume 152, 2001 642
factor or angiopoietin-1 results in enhanced Akt activation
and protection against serum withdrawal–induced apopto-
sis (Fujikawa et al., 1999; Fujio and Walsh, 1999; Kim et
al., 2000; Papapetropoulos et al., 2000). At present, we do
not know how the PI 39-kinase/Akt signaling pathway in-
hibits anoikis in HUVECs, but it does not do so by inhibit-
ing the expression of Fas and Fas-L or by upregulating the
expression of c-Flip (data not shown). Previous studies
have identified several targets for the antiapoptotic func-
tion of Akt, and include inactivation of the proapoptotic
proteins Bad and Bax and of caspase-9 (Datta et al., 1999),
all of which participate in mitochondria-regulated apopto-
sis. Our hypothesis is that activation of the mitochondrial
death pathway downstream of caspase-8 activation is re-
quired for anoikis and Fas-mediated apoptosis to take
place in endothelial cells; indeed, oxidized LDL-induced
Fas-mediated death in HUVECs can be blocked by Bcl-xL
expression, which functions prosurvival at the level of mi-
tochondria (Sata and Walsh, 1998a). Bcl-xL has also been
found to protect against anoikis in epithelial cells (Ry-
tomaa et al., 1999; Rosen et al., 2000). Thus, activated PI
39-kinase and Akt molecules may block anoikis in de-
tached cells by preventing activation of the mitochondrial
death pathway in HUVECs, whereas inactivation of this
survival pathway in and of itself in attached endothelial
cells does not activate death signaling.
Ilic and coworkers (1998) have recently demonstrated
that when serum is absent, correct matrix attachment
transduces survival signals via FAK to suppress p53-regu-
lated apoptosis in primary fibroblasts and endothelial
cells. The same authors have also found that activation of
the c-Jun NH2-terminal kinase (JNK) pathway down-
stream of FAK is required for anchorage-dependent sur-
vival under these conditions (Almeida et al., 2000). In our
experimental system, in which apoptosis is induced in en-
dothelial cells via stimulation of Fas or by cell detachment
in the presence of serum, we found no indication that the
FAK/JNK/p53 pathway would have a crucial role in regu-
lating cell survival. Thus, dominant negative forms of FAK
and JNK kinase (JNKK) (Ilic et al., 1998; Almeida et al.,
2000) failed to sensitize cells to Fas-mediated apoptosis,
even when the Fas receptor was exogenously expressed in
the cells. Along the same lines, expression of dominant
negative forms of FAK and JNKK had no effect on the ex-
pression levels of c-Flip. This finding is in accordance with
the observation that FAK does not mediate adhesion-
dependent Erk activation in HUVECs (data not shown;
Barberis et al., 2000). Also, we used a dominant negative
form of p53 (GSE 56) (Ossovskaya et al., 1996) to inhibit
p53 function in HUVECs and found that suppression of p53
activity does not rescue HUVECs from Fas-induced or de-
tachment-induced apoptosis. Taken together, our results
indicate that the commitment to the Fas-mediated death
pathway, which in our model system is activated either by
treating cells with the agonistic Fas-antibody CH11 or by
cell detachment in the presence of serum, appears to be
distinct from commitment to p53-regulated apoptosis that
is initiated upon withdrawal of ECM under serum-free
conditions. This notion is supported by the earlier finding
that CrmA, which blocks Fas-induced apoptosis, does not
block p53-regulated apoptosis triggered either by FAK in-
activation or by culture of cells on an inappropriate ECM
in the absence of serum (Ilic et al., 1998). Along the same
lines, we find that detachment-induced cell death in the
absence of serum is not inhibitable by caspase-8 inhibitors
(not shown).
Our results indicate that attached HUVECs that over-
express Fas and caspase-8, despite the fact that they con-
stitutively express Fas-L on the cell surface, are not apop-
totic unless the agonistic Fas antibody CH11 is added to
the cultures. Our studies further indicate that Fas-L and
Fas do not interact in attached cells (data not shown). It
has been demonstrated recently that epithelial cell detach-
ment activates a metalloproteinase that cleaves Fas-L to
produce soluble Fas-L, which then binds to Fas and in-
duces apoptosis (Powell et al., 1999). We have tested the
possibility that cleavage of Fas-L would take place upon
cell detachment and that this processing would be re-
quired for anoikis in endothelial cells, and we found that
this is unlikely to be the case in HUVECs. First, the only
form of Fas-L that can be immunoprecipitated from at-
tached or detached HUVEC lysates or conditioned media
has a molecular mass of 37 kD, which corresponds to the
membrane form of Fas-L. Second, addition of metallopro-
teinase inhibitors that have been shown to block process-
ing of soluble Fas-L has no effect on the cell surface ex-
pression levels of Fas-L; inhibition of soluble Fas-L
formation by these inhibitors should result in an increase
in the amount of membrane-bound Fas-L (Kayagaki et al.,
1995). Finally, addition of metalloprotease inhibitors had,
unlike in epithelial cells (Powell et al., 1999), no effect on
anoikis in HUVECs (data not shown). It is possible that
when cultured as a monolayer, the cell–cell contacts in
HUVECs are not optimal to allow Fas/Fas-L interaction
to occur. When endothelial cells are grown in suspension
or on polyhema to induce anoikis, the cells become round
and form cell aggregates via a yet-to-be-determined mech-
anism (data not shown), and it may be that this aggrega-
tion is crucial for Fas/Fas-L interaction and induction of
Fas-mediated apoptosis in detached cells. The possibility
that induction of anoikis in endothelial cells would involve
a previously unidentified processing and/or activation
mechanism at the level of Fas/Fas-L interaction cannot be
ruled out and warrants further studies.
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